|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
Q4 FY2021
As of Jun 30, 2021
|
Q3 FY2021
As of Mar 31, 2021
|
Q2 FY2021
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Cash and due from banks | |||||||||||||||||
| Interest bearing deposits with other banks | |||||||||||||||||
| Federal funds sold | |||||||||||||||||
| Total cash and cash equivalents | |||||||||||||||||
| Interest-bearing time deposits | |||||||||||||||||
| Securities available for sale, at fair value | |||||||||||||||||
| Securities held to maturity, net of allowance for credit losses of $0 as of December 31, 2024 and June 30, 2024 (fair value of $68,316 and $76,827 as of December 31, 2024 and June 30, 2024, respectively) | |||||||||||||||||
| Securities held to maturity, net of allowance for credit losses of $0 as of June 30, 2024 (fair value of $76,827 and $82,313, as of June 30, 2024 and 2023, respectively) | |||||||||||||||||
| Equity securities | |||||||||||||||||
| Loans receivable, net of allowance for credit losses of $2,598 and $2,989 as of December 31, 2024 and June 30, 2024, respectively | |||||||||||||||||
| Loans receivable, net of allowance for credit losses of $2,989 and $3,313 as of June 30, 2024 and 2023, respectively | |||||||||||||||||
| Premises and equipment, net | |||||||||||||||||
| Regulatory stock, at cost | |||||||||||||||||
| Deferred income taxes | |||||||||||||||||
| Bank-owned life insurance | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Intangible assets | |||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||
| Accrued interest receivable and other assets | |||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||
| LIABILITIES | |||||||||||||||||
| Deposits | |||||||||||||||||
| Advances from Federal Home Loan Bank | |||||||||||||||||
| Advances from borrowers for taxes and insurance | |||||||||||||||||
| Operating lease liabilities | |||||||||||||||||
| Accrued interest payable and other liabilities | |||||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||||
| STOCKHOLDERS' EQUITY | |||||||||||||||||
| Common stock, $0.01 par value, 150,000,000 shares authorized; 9,208,217 shares issued and outstanding at December 31, 2024 and 9,343,900 shares issued and outstanding at June 30, 2024 | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Unearned common stock held by employee stock ownership plan | |||||||||||||||||
| Retained earnings | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | |||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||
Loading...
